11. Older adults may not consider life expectancy an important factor in cancer screening. (20th November 2017) Authors: Chung, Clement Journal: CA Issue: Volume 68:Number 1(2018) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Optimizing Multidisciplinary Treatment-Related Adverse Effects Detection and Reduction in Patients Undergoing Active Cancer Treatments in Ambulatory Infusion Centers. Issue 9 (1st September 2022) Authors: Chung, Clement; Rome, Alison; Desai, Monica; Abanonu, Fred; De la Casas, Cesar Journal: JCO oncology practice Issue: Volume 18:Issue 9(2022) Page Start: e1553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation. (February 2014) Authors: Chung, Clement; Christianson, Matthew Journal: Journal of oncology pharmacy practice Issue: Volume 20:Number 1(2014:Mar.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation. (June 2022) Authors: Chung, Clement Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 4(2022) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy‐induced amenorrhea. (20th November 2017) Authors: Chung, Clement Journal: CA Issue: Volume 68:Number 1(2018) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy. Issue 1 (6th January 2017) Authors: Chung, Clement Journal: Pharmacotherapy Issue: Volume 37:Issue 1(2017) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies. Issue 4 (April 2022) Authors: Chung, Clement Journal: Annals of pharmacotherapy Issue: Volume 56:Issue 4(2022) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade. (April 2019) Authors: Chung, Clement Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 3(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics. (June 2016) Authors: Chung, Clement Journal: Journal of oncology pharmacy practice Issue: Volume 22:Number 3(2016:Sep.) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗